Case studies

Hovione - TwinCaps® inhaler

In response to the 2006 global threat of a flu pandemic, Hovione was asked to develop and manufacture an inhalation device capable of delivering an influenza anti-viral drug.

  • Client
    Hovione
Hovione

The world’s best-selling, disposable inhaler

H

Hovione came to TTP with a clear brief and a device requirement matched to a single formulation for the Japanese market.

In order to meet tight commercial timelines driven by the Japanese government’s flu pandemic fears, we needed a project plan that went from concept generation to first moulded prototypes in less than two months.

TTP assembled a small, dedicated team to leverage core knowledge of design and manufacturing principles to take on the challenge.

Our response was TwinCaps®: a two-component, single-dose, dry powder inhaler for systemic delivery.

Focusing on one design concept, and by means of early and repeated prototyping coupled with a concurrent engineering approach, TTP was able to meet the incredibly short product launch deadlines.

Hovione Inuse
Quote

Launched by Daiichi Sankyo, Japan’s second largest pharmaceutical company, TwinCaps® outsold Relenza and Tamiflu within the first six months and is the world’s best-selling, disposable inhaler.

Get in touch


Next up

Mayflower wireless technology

Mayflower approached TTP with aggressive cost, performance and reliability targets for a new remotely controlled, street lighting solution. TTP's extensive experience in design for manufacture, wireless systems and cost engineering allowed us to exceed their expectations.

  • Client
    Mayflower
Street Lighting

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.